Increased Metabolic Activity in Abdominal Aortic Aneurysm Detected by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT)

European Journal of Vascular and Endovascular Surgery

Volumn 38, Issue 1, 2009, Pages 93-99

  Kotze, C W ^a   Menezes, L J ^b   Endozo, R ^b   Groves, A M ^b   Ell, P J ^b   Yusuf, S W ^a  

^a UK   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

18F fluorodeoxyglucose (18F FDG) positron emission tomography computed tomography; Abdominal aortic aneurysm

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM; ANEURYSM SURGERY; ARTICLE; CALCIFICATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SURVEILLANCE; DRUG UPTAKE; GLUCOSE METABOLISM; HUMAN; IN VIVO STUDY; INFLAMMATORY ANEURYSM; MALE; METABOLIC ACTIVATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCORING SYSTEM; STANDARDIZED UPTAKE VALUE;

AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; ENERGY METABOLISM; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS;

EID: 67349169499     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2008.12.016     Document Type: Article

References (29)

1. Brown P.M., Zelt D.T., and Sobolev B. The risk of rupture in untreated aneurysms: the impact of size, gender, and expansion rate. J Vasc Surg 37 (2003) 280-284
2. Limet R., Sakalihassan N., and Albert A. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg 14 (1991) 540-548
3. Sterpetti A.V., Cavallaro A., Cavallari N., Allegrucci P., Tamburelli A., Agosta F., et al. Factors influencing the rupture of abdominal aortic aneurysms. Surg Gynecol Obstet 173 (1991) 175-178
4. Johansson G., Nydhal S., Olofsson P., and Swedenborg J. Survival in patients with abdominal aortic aneurysms: comparison between operative and non-operative management. Eur J Vasc Surg 4 (1990) 497-502
5. Fillinger M.F., Racusin J., Baker R.K., Cronenwett J.L., Teutelink A., Schermerhorn M.L., et al. Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: implications for rupture risk. J Vasc Surg 39 (2004) 1243-1252
6. Fillinger M.F., Marra S.P., Raghavan M.L., and Kennedy F.E. Prediction of rupture risk in abdominal aortic aneurysm during observation: wall stress versus diameter. J Vasc Surg 37 (2003) 724-732
7. Sakalihasan N., Van Damme H., Gomez P., Rigo P., Lapiere C.M., Nusgens B., et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg 23 (2002) 431-436
8. Shimizu K., Mitchell R.N., and Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26 (2006) 987-994
9. Lindholt J.S., and Shi G.P. Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 31 (2006) 453-463
10. Lindholt J.S., Vammen S., Fasting H., Henneberg E.W., and Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 20 (2000) 281-285
11. Schirmer M., Duftner C., Seiler R., Dejaco C., and Fraedrich G. Abdominal aortic aneurysms: an underestimated type of immune-mediated large vessel arteritis?. Curr Opin Rheumatol 18 (2006) 48-53
12. Choke E., Cockerill G., Wilson W.R., Sayed S., Dawson J., Loftus I., et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 30 (2005) 227-244
13. Ailawadi G., Eliason J.L., and Upchurch Jr. G.R. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg 38 (2003) 584-588
14. Mochizuki T., Tsukamoto E., Kuge Y., Kanegae K., Zhao S., Hikosaka K., et al. FDG uptake and glucose transporter subtype expression in experimental tumor and inflammation models. J Nucl Med 42 (2001) 1551-1555
15. Tawakol A., Migrino R.Q., Hoffmann U., Abbara S., Houser S., Gewirtz H., et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 12 (2005) 255-257
16. Ben-Haim S., Kupzov E., Tamir A., and Israel O. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 45 (2004) 1816-1821
17. Reeps C., Essler M., Pelisek J., Seidl S., Eckstein H.H., and Krause B.J. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg 48 (2008) 417-423
18. Sakalihasan N., Hustinx R., and Limet R. Contribution of PET scanning to the evaluation of abdominal aortic aneurysm. Semin Vasc Surg 17 (2004) 144-153
19. Rudd J.H., Warburton E.A., Fryer T.D., Jones H.A., Clark J.C., Antoun N., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 (2002) 2708-2711
20. Tawakol A., Migrino R.Q., Bashian G.G., Bedri S., Vermylen D., Cury R.C., et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48 (2006) 1818-1824
21. Arrivé L., Corréas J.M., Lesèche G., Ghebontni L., and Tubiana J.M. Inflammatory aneurysms of the abdominal aorta: CT findings. AJR Am J Roentgenol 165 (1995) 1481-1484
22. Rose A.G., and Dent D.M. Inflammatory variant of abdominal atherosclerotic aneurysm. Arch Pathol Lab Med 105 (1981) 409-413
23. Rappeport E.D., Loft A., Berthelsen A.K., et al. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48 (2007) 369-378
24. Takahashi M., Momose T., Kameyama M., and Ohtomo K. Abnormal accumulation of [18F]fluorodeoxyglucose in the aortic wall related to inflammatory changes: three case reports. Ann Nucl Med 20 (2006) 361-364
25. Vega de Céniga M., Gómez R., Estallo L., Vega de Céniga M., Gómez R., Estallo L., et al. Analysis of expansion patterns in 4-4.9 cm abdominal aortic aneurysms. Ann Vasc Surg 22 (2008) 37-44
26. Baud J.M., Mas D., Pichot O., Laroche J.P., Viard A., Crévillier M., et al. Criteria for quantification and characterization of aneurysms of the abdominal aorta using ultrasonography. The AFFCA study. French Association of Continuous Education in Angiology. J Mal Vasc 22 (1997) 313-320
27. Sprouse II L.R., Meier III G.H., Lesar C.J., Demasi R.J., Sood J., Parent F.N., et al. Comparison of abdominal aortic aneurysm diameter measurements obtained with ultrasound and computed tomography: is there a difference?. J Vasc Surg 38 (2003) 466-471
28. Li Z.Y., U-King-Im J., Tang T.Y., Soh E., See T.C., and Gillard J.H. Impact of calcification and intraluminal thrombus on the computed wall stresses of abdominal aortic aneurysm. J Vasc Surg 47 (2008) 928-935
29. Tatsumi M., Cohade C., Nakamoto Y., and Wahl R.L. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology 229 (2003) 831-837